WallStreetZenWallStreetZen

NASDAQ: QNCX
Quince Therapeutics Inc Stock Ownership - Who owns Quince Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Quince Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dirk ThyeCEO and CMO2025-06-18150,944$1.20
$181.13kBuy
Brendan HannahCBO COO CCO2025-06-1837,736$1.20
$45.28kBuy
Charles S. RyanPresident2025-06-187,548$1.20
$9.06kBuy
Dirk ThyeCEO AND CHIEF MEDICAL OFFICER2024-08-3077,000$0.70
$53.90kBuy
Dirk ThyeCEO AND CHIEF MEDICAL OFFICER2024-08-2977,500$0.69
$53.47kBuy
Brendan HannahCHIEF BUSINESS OFFICER AND COO2024-08-2123,565$0.63
$14.85kBuy
Brendan HannahCHIEF BUSINESS OFFICER AND COO2024-08-212,280$0.61
$1.39kBuy
Brendan HannahCHIEF BUSINESS OFFICER AND COO2024-08-215,000$0.62
$3.10kBuy
Brendan HannahCHIEF BUSINESS OFFICER AND COO2024-08-202,500$0.61
$1.53kBuy
Charles S. RyanPRESIDENT2024-08-2048,387$0.65
$31.45kBuy

1 of 2

QNCX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when QNCX insiders and whales buy or sell their stock.

QNCX Shareholders

What type of owners hold Quince Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Epiq Capital Group LLC50.04%22,753,059$37.54MInsider
David Lamond9.64%4,384,096$7.23MInsider
Pierre Lamond6.35%2,886,530$4.76MInsider
Pfizer Inc6.33%2,879,973$4.75MInsider
Takeda Ventures Inc5.89%2,679,802$4.42MInsider
Stephen S. Dominy3.16%1,437,674$2.37MInsider
Vanguard Group Inc2.83%1,285,773$2.12MInstitution
Casey Lynch2.60%1,180,580$1.95MInsider
Dirk Thye2.19%994,885$1.64MInsider
Ieq Capital LLC1.77%806,780$1.33MInstitution

1 of 3

QNCX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
QNCX11.26%88.74%Net BuyingNet Buying
IPA8.52%0.00%
CABA71.55%8.32%
IGMS29.64%54.23%Net SellingNet Selling
MIST22.12%24.77%
View Top Biotech Stocks

Quince Therapeutics Stock Ownership FAQ

Who owns Quince Therapeutics?

Quince Therapeutics (NASDAQ: QNCX) is owned by 11.50% institutional shareholders, 90.64% Quince Therapeutics insiders, and 0.00% retail investors. Epiq Capital Group LLC is the largest individual Quince Therapeutics shareholder, owning 22.75M shares representing 50.04% of the company. Epiq Capital Group LLC's Quince Therapeutics shares are currently valued at $38.45M.

If you're new to stock investing, here's how to buy Quince Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.